Squarepoint
SGRY icon

Squarepoint’s Surgery Partners SGRY Stock Holding History

Squarepoint’s Portfolio SGRY Stock Details SGRY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$308K Buy
+18,333
New +$257K ﹤0.01% 3787
2025
Q4 		– Sell
-16,265
Closed -$352K – 4824
2025
Q3 		$352K Sell
16,265
-36,801
-69% -$821K ﹤0.01% 3544
2025
Q2 		$1.18M Sell
53,066
-154,971
-74% -$3.44M ﹤0.01% 2520
2025
Q1 		$4.94M Buy
+208,037
New +$4.92M 0.01% 1429
2024
Q2 		– Sell
-39,406
Closed -$1.18M – 4587
2024
Q1 		$1.18M Buy
39,406
+20,785
+112% +$650K ﹤0.01% 2480
2023
Q4 		$596K Sell
18,621
-17,185
-48% -$499K ﹤0.01% 2878
2023
Q3 		$1.05M Buy
+35,806
New +$1.29M ﹤0.01% 2289
2022
Q4 		– Sell
-55,244
Closed -$1.29M – 3555
2022
Q3 		$1.29M Buy
55,244
+47,327
+598% +$1.51M 0.01% 1588
2022
Q2 		$229K Buy
+7,917
New +$346K ﹤0.01% 2402
2022
Q1 		– Sell
-9,491
Closed -$507K – 3445
2021
Q4 		$507K Buy
9,491
+4,548
+92% +$211K ﹤0.01% 2133
2021
Q3 		$209K Buy
4,943
+390
+9% +$19.9K ﹤0.01% 2467
2021
Q2 		$303K Sell
4,553
-20,257
-82% -$1.1M ﹤0.01% 2524
2021
Q1 		$1.1M Buy
+24,810
New +$921K 0.01% 1434
2020
Q4 		– Sell
-35,611
Closed -$780K – 3224
2020
Q3 		$780K Buy
35,611
+4,900
+16% +$87.1K 0.01% 1134
2020
Q2 		$355K Buy
+30,711
New +$337K 0.01% 1501
2020
Q1 		– Sell
-17,200
Closed -$269K – 2439
2019
Q4 		$269K Sell
17,200
-78,558
-82% -$891K ﹤0.01% 2094
2019
Q3 		$707K Buy
95,758
+46,891
+96% +$336K 0.01% 1434
2019
Q2 		$398K Buy
+48,867
New +$487K ﹤0.01% 1790
2019
Q1 		– Sell
-70,405
Closed -$689K – 2405
2018
Q4 		$689K Buy
70,405
+50,620
+256% +$679K 0.01% 1079
2018
Q3 		$326K Buy
+19,785
New +$316K ﹤0.01% 1494
2018
Q1 		– Sell
-22,681
Closed -$274K – 2098
2017
Q4 		$274K Sell
22,681
-8,783
-28% -$84K ﹤0.01% 1574
2017
Q3 		$326K Buy
+31,464
New +$450K 0.01% 1139

Other funds holding SGRY

BCI
Bain Capital Investors Boston, Massachusetts $4.82B AUM 35.43% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
PCM
Pentwater Capital Management Naples, Florida $16.4B AUM 55.44% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
KSCM
King Street Capital Management New York $190M AUM 16.01% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Squarepoint's SGRY Position: Q2 2026 in Review

Squarepoint opened a new position in Surgery Partners (SGRY) in Q2 2026: 18,333 shares worth $308K. The stake represents ﹤0.01% of the portfolio and ranks #3787 among its holdings. This is a return to the name: Squarepoint previously reported a position in SGRY as recently as Q3 2025.

Squarepoint first reported a position in SGRY in Q3 2017 and has held it in 22 quarters since. The position peaked at $4.94M in Q1 2025. 188 funds tracked by Wall St. Rank hold SGRY as of Q2 2026.

  • Squarepoint held 18,333 shares of Surgery Partners worth $308K as of Q2 2026.
  • Surgery Partners was a new Squarepoint position in Q2 2026.
  • Surgery Partners made up ﹤0.01% of Squarepoint's portfolio in Q2 2026, its #3787 holding.
  • Squarepoint first reported a position in Surgery Partners in Q3 2017 and has held it in 22 quarters since.
  • Squarepoint's Surgery Partners position peaked at $4.94M in Q1 2025.
  • 188 funds tracked by Wall St. Rank held Surgery Partners as of Q2 2026.

Based on Squarepoint's 13F filing for Q2 2026, filed 14 Aug 2026.